Saballa, Michael Anthony S.

HRN: 07-03-98  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2026
CEFTAZIDIME 1GM (VIAL)
06/13/2026
06/20/2026
IV
2g Now Then 1 Gram
Q 8
T/C PTB
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: